FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | Congress

SPOTLIGHT: FDA backpedals on inspection funding

Tools


Now you see it, now you don't. Congress thought--or pretended to think, you never know on Capitol Hill--that the FDA had ball-parked the funding it needs to beef up foreign inspections. That would be $225 million, a number contributed by CDER chief Janet Woodcock on Wednesday. But Thursday at a hearing of the House Energy and Commerce Committee, Woodcock backed away from that figure. FDA report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about FDA   Congress